← All trials
NCT04859062
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2021
- Primary completion
- Apr 1, 2022
- Completion date
- Apr 1, 2022
- First posted
- Apr 26, 2021
- Last posted
- Sep 19, 2022
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Research Institute of Ophthalmology, EgyptLead sponsor
- Research Institute of Ophthalmology, EgyptReponsible party - principal investigator
- Research Institute of Ophthalmology, EgyptSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.